| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/16/2005 | EP1513836A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 03/16/2005 | EP1513835A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 03/16/2005 | EP1513834A1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same |
| 03/16/2005 | EP1513831A1 Novel compounds, their use and preparation |
| 03/16/2005 | EP1513830A1 Bisindolyl-maleimid derivatives as kinase inhibitors |
| 03/16/2005 | EP1513828A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders |
| 03/16/2005 | EP1513827A1 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors |
| 03/16/2005 | EP1513813A1 Opioid receptor antagonists |
| 03/16/2005 | EP1513811A1 Non-peptidic brs-3 agonists |
| 03/16/2005 | EP1513810A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans |
| 03/16/2005 | EP1513808A2 Fluorinated cyclic amides as dipeptidyl peptidase iv inhibitors |
| 03/16/2005 | EP1513803A1 Ligands that are inhibitors of the rar receptors |
| 03/16/2005 | EP1513800A1 N-benzoylureidocinnamate derivatives, method for production and use thereof |
| 03/16/2005 | EP1513796A2 Phenyloxyalkanoic acid derivatives as hppar activators |
| 03/16/2005 | EP1513795A2 Propionic acid derivatives and their use as hppars activators |
| 03/16/2005 | EP1513589A1 1,5-disubstituted pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma |
| 03/16/2005 | EP1513536A1 Use of compounds that stimulate cgmp |
| 03/16/2005 | EP1513529A1 Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 03/16/2005 | EP1513526A1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators |
| 03/16/2005 | EP1513520A2 Substituted pyrrolines as kinase inhibitors |
| 03/16/2005 | EP1513519A1 The use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases |
| 03/16/2005 | EP1513516A1 SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS ANDPROCESSES FOR PREPARING AND THEIR USES |
| 03/16/2005 | EP1513482A2 Topical use of at least one double-stranded rna oligonucleotide (ds rna) |
| 03/16/2005 | EP1513419A2 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 03/16/2005 | EP1513418A2 Use of pullulan as a slowly digested carbohydrate |
| 03/16/2005 | EP1392699B1 6h-oxazolo 4,5-e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 03/16/2005 | EP1250358B1 Therapeutic peptides |
| 03/16/2005 | EP1233959B1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 03/16/2005 | EP1140900B1 Pyrazole compounds and uses thereof |
| 03/16/2005 | EP1044016B1 Stabilised insulin compositions |
| 03/16/2005 | EP0948609B1 Llg polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies |
| 03/16/2005 | EP0837681B1 Use of 19-nor-vitamin d compounds for the prevention of hyperphosphatemia in kidney disorder patients |
| 03/16/2005 | EP0808164B1 Use of prolactin modulators and diet for the manufacture of a medicament for the treatment of obesity |
| 03/16/2005 | EP0769917B2 Nervonic acid compositions |
| 03/16/2005 | EP0746321B1 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| 03/16/2005 | CN1596305A Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof |
| 03/16/2005 | CN1596266A Specific binding agents of human angiopoietin-2 |
| 03/16/2005 | CN1596264A Differentially expressed genes associated with obesity and type 2 diabetes |
| 03/16/2005 | CN1596263A Aryl fused azapolycyclic compounds |
| 03/16/2005 | CN1596257A Novel crystalline compound |
| 03/16/2005 | CN1596255A Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 03/16/2005 | CN1596253A Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 03/16/2005 | CN1596249A Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them |
| 03/16/2005 | CN1596247A Lactam derivatives as antagonists for human 11CBY receptors |
| 03/16/2005 | CN1596240A Chalcone derivatives and their use to treat diseases |
| 03/16/2005 | CN1596128A Pharmaceutical compositions of 5, 7, 14-triazatetracyclo[10.3.1.0(2, 11).0(4, 9)]-hexadeca-2(11)3, 5, 7, 9-pentaene |
| 03/16/2005 | CN1596127A Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 03/16/2005 | CN1596119A Modification of feeding behavior |
| 03/16/2005 | CN1596115A Treatment of hyperproliferative diseases using active vitamin D analogues |
| 03/16/2005 | CN1596114A Substituted 1, 4-benzodiazepines and uses thereof for the treatment of cancer |
| 03/16/2005 | CN1596106A Use of trifluoroacetyl alkyl-substituted phenyl derivatives, phenol derivatives, and benzoyl derivatives in the treatment and/or prophylaxis of obesity and accompanying diseases and/or secondary disea |
| 03/16/2005 | CN1596103A Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type II diabetes mellitus |
| 03/16/2005 | CN1594366A Oil soluble O-chitosan derivatives and their preparation and use |
| 03/16/2005 | CN1594365A Water and oil soluble O-chitosan derivatives and their preparation and use |
| 03/16/2005 | CN1594316A Substituted pyrazolone derivatives and their preparing process and pharmaceutical conpositions |
| 03/16/2005 | CN1594306A Genistein-3'-sodium sulfonate, dimethylation daidzein-3'-sodium sulfonate, their preparing process and pharmaceutical use |
| 03/16/2005 | CN1594246A Rhizoma Anemarrhenae total phenol extract, its preparation method and application |
| 03/16/2005 | CN1593650A Effervescence tablet of human antalzyme, its preparation and usage |
| 03/16/2005 | CN1593649A Method for preparing insulin oral formulation |
| 03/16/2005 | CN1593647A Nutrient and healthy capsule of active ass hide |
| 03/16/2005 | CN1593646A Soybean peptide, its preparation and application |
| 03/16/2005 | CN1593643A Medicinal composition for preventing and treating cardiovascular heart disease and its preparation |
| 03/16/2005 | CN1593600A Nutrition regulating and fit keeping method |
| 03/16/2005 | CN1593598A Effective site extract of lotus plumule and its usage |
| 03/16/2005 | CN1593585A Blood fat regulating healthy product |
| 03/16/2005 | CN1593570A Blood fat lowering Chinese traditional medicine |
| 03/16/2005 | CN1593551A Blood fat lowering capsule or tablet and its preparation |
| 03/16/2005 | CN1593536A Blood fat regulating medicine and its preparation |
| 03/16/2005 | CN1593534A Blood sugar lowering capsules and preparation thereof |
| 03/16/2005 | CN1593511A Nutrient for promoting animal growth and its preparing process |
| 03/16/2005 | CN1593510A Method for preparing Chinese medicinal formulation of dog button |
| 03/16/2005 | CN1593497A Novel blood sugar lowering medicine and its preparing process |
| 03/16/2005 | CN1593480A Fig buccal tablet and its preparing process |
| 03/16/2005 | CN1593475A Novel use for mixture of astragalus root and angelica |
| 03/16/2005 | CN1593465A Soft capsule of forest frog oil and its preparation method |
| 03/16/2005 | CN1593462A Insulin secretory cell extract and its application in inducing stem cell differentiation |
| 03/16/2005 | CN1593461A Nutrient oral liquor of ass hide glue flavone |
| 03/16/2005 | CN1593460A Nutrient capsule of ass hide glue flavone |
| 03/16/2005 | CN1593458A Instant nutrition intensifying agent |
| 03/16/2005 | CN1593455A Compound baking soda injection and its preparation |
| 03/16/2005 | CN1593449A self emulsifying soft capsule of breviscapine and its preparation |
| 03/16/2005 | CN1593435A Sustained release/controlled release medicine for treating high blood fat |
| 03/16/2005 | CN1593432A Alendronate sodium powder for injection |
| 03/16/2005 | CN1593401A Easily absorbed simvastatin soft capsule composition |
| 03/16/2005 | CN1193026C Z-pyrazoline-5-ones |
| 03/16/2005 | CN1193025C Novel 1, 3-dihydro-2H-indol-2-one derivatives, their preparing method and pharmceutical composition containing the same |
| 03/16/2005 | CN1192999C Aromatic di-ceto-derivatives use as glucose-6-phosphate translocase inhibitors |
| 03/16/2005 | CN1192790C Sugar-reducing capsule and its preparation method |
| 03/16/2005 | CN1192789C Diabetes treating tea and preparing method thereof |
| 03/15/2005 | US6867313 Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same |
| 03/15/2005 | US6867306 Process for the synthesis of atorvastatin form v and phenylboronates as intermediate compounds |
| 03/15/2005 | US6867234 Fat composition for oral or enternal administration and hexacosanoic acid depressant |
| 03/15/2005 | US6867225 Alpha type human peroxisome proliferator activated receptor agonists; such as 2-methyl-2-(3-methyl-4-(((4-phenoxymethyl-2-(4-trifluoromethylphenyl) -thiazol-5-yl-carbonyl)-amino)-methyl)phenoxy)propionic acid |
| 03/15/2005 | US6867224 Thiazole or oxazole derivatives such as 5-(4-Methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl)-indan-2-carboxylic acid |
| 03/15/2005 | US6867222 Nociceptin analogs |
| 03/15/2005 | US6867220 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them |
| 03/15/2005 | US6867215 Cardioprotective phosphonates and malonates |
| 03/15/2005 | US6867205 Useful for the treatment and/or prophylaxis of diseases associated with dipeptidyl peptidase, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance |
| 03/15/2005 | US6867202 Treatment of insulin resistance |
| 03/15/2005 | US6867193 Prevents onset of hepatic encephalopathy |